Phaarmasia informs about closure of trading window

30 Mar 2024 Evaluate
Phaarmasia has informed that in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, the Company has intimated to all its Directors, Key Management Personnel and Designated Employees regarding the Closure of the Trading Window of the Company from 01.04.2024 till 48 hours from the conclusion of Board meeting in which the Unaudited Financial result for the Quarter and year ended 31st March, 2024 will be approved. This closure of the Trading Window is occasioned by reason of declaration of financial results for the quarter and year ended 31 March, 2024. All the insiders (including Directors, Key Managerial Personnel and designated employees) and their immediate relatives are hereby directed to take notice that in terms of trading restrictions placed under above regulations, shares of the Company shall not be dealt in during the period of closure of Trading Window as stated above. 

The above information is a part of company’s filings submitted to BSE.

Phaarmasia Share Price

106.25 -2.16 (-1.99%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×